Formulation and evaluation of coencapsulated rifampicin and isoniazid liposomes using different lipids

Acta Pharmaceutica Sciencia

Volumn 51, Issue 2, 2009, Pages 177-188

  Karki, Roopa ^a   Subramanya, G ^b   Udupa, N ^b  

^a ACHARYA AND B M REDDY COLLEGE OF PHARMACY   (India)

^b MANIPAL COLLEGE OF PHARMACEUTICAL SCIENCES   (India)

Author keywords

Isoniazid; Liposome; Rifampicin; Tuberculosis

Indexed keywords

CHOLESTEROL; DIPLAMITOYLPHOSPHATIDYLCHOLINE; EGGPHOSPHATIDYLCHOLINE; ISONIAZID; LIPID; LIPOSOME; RIFAMPICIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG FORMULATION; DRUG HALF LIFE; DRUG RELEASE; DRUG STABILITY; ENCAPSULATION; HISTOPATHOLOGY; HYDRATION; LIPID COMPOSITION; LIPOSOMAL DELIVERY; LIVER TOXICITY; MALE; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PARTICLE SIZE; PH MEASUREMENT; RAT; TEMPERATURE MEASUREMENT;

EID: 70349705770     PISSN: 13072080     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Al-Angary, A.A., Al-Meshal, M.A., Bayomi, M.A., Khidr, S.H. (1996). Evaluation of liposomal formulation containing the antimalarial agent, arteether, Int. J. Pharm. 128: 163-168.
2. Alliga, S.A., Eley, D.D., and Hey, M.J. (1979). A nuclear magnetic relaxation study of bound water in solutions of disodium cromoglyate, J. Pharm.Pharmacol. 31: 387-391. (Pubitemid 9205549)
3. Azamin, M.N., Florance, A.T., Handjani V.R.M., Stewart, J.F., Vanlerberghe, G., and Whittaker, J.S. (1985). The effect of non-ionic surfactant vesicles (niosomes) entrapment on the absorption and distribution of Methotrexate in mice, J. Pharm. Pharmcol. 37: 237-242.
4. Betageri, G.V., and Parsons, D.L. (1992). Drug encapsulation and release from multilamellar and unilamellar liposomes, Int. J. Pharm. 81: 35-241.
5. Deol, P., and Khuller, G.K., (1997). Lung specific stealth liposomes: Stability biodistribution and toxicity of liposomal antitubercular drugs in mice. Biochem. Et .Biophysica. Acta. 1334: 161-172.
6. Dutta, S., Karki, R., Shivananda, P.G., and Udupa, N. (2000). Liposome encapsulated rifampicin and isoniazid, Indian. J .Pharm. 62: 384-387.
7. st century, Clin. Infect. Dis. 32: 675-685.
8. Goodman and Gillman (1985). The Pharmacological basis of therapeutics. New York: Mac Millan Publishing Company 9th edition; pp1199.
9. Gürsoy, E, K., Özkirimli, S. (2004). Co encapsulation of isoniazid and rifampicin in liposomes and characterization of liposome by derivative spectroscopy, Int. J. Pharm. 27: 115-123.
10. Jain, C.P., and Vyas S.P., Niosomes of rifampicin as lung targeting, (1995). J. Microenspsulation 12: 401-407.
11. Puglisi, G., Frester, M., Mazzone, G., Purneri, P.M., Temperu, G., (1995). Formulation parameters of fluoroquiolone loaded liposomes and in vitro anti microbial activity, Int. J. Pharm. 118: 65-76.
12. Srinath, P., Chary, M.G., Vyas, S.P., Diwan, P.V. (2000). Long-circulating liposomes of indomethacin in arthritic rats-a biodisposition study, J. Cont. Release 74: 399-404.